Approaches to pathogenetic therapy of spinal muscular atrophy in children and newborns
Spinal muscular atrophy (SMA) is a hereditary, autosomal recessive disease that debuts at different ages. Neurological symptoms are progressive and lead to significant limitation of life activity and reduced life expectancy. Currently, there are several drugs for the pathogenetical treatment of SMA....
Saved in:
Main Authors: | S. B. Artemyeva, O. A. Shidlovskaya, Yu. O. Papina, A. V. Monakhova, I. V. Shulyakova, E. D. Belousova, O. Yu. Germanenko, D. V. Vlodavets |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2024-03-01
|
Series: | Нервно-мышечные болезни |
Subjects: | |
Online Access: | https://nmb.abvpress.ru/jour/article/view/593 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characteristics of genetic changes in the <i>SMN1</i> gene in spinal muscular atrophy 5q
by: A. V. Dil, et al.
Published: (2022-09-01) -
Assessment of social emotional, cognitive and communicative development and adaptive behavior in children with spinal muscular atrophy 5q
by: Yu. O. Papina, et al.
Published: (2025-04-01) -
Factors modifying the course of spinal muscular atrophy 5q
by: M. A. Akhkiamova, et al.
Published: (2024-01-01) -
Functional class criteria identification in patients with spinal muscular atrophy 5q
by: Yu. O. Papina, et al.
Published: (2024-12-01) -
Diagnostic criteria for spinal muscular atrophy 5q
by: I. V. Sharkova, et al.
Published: (2021-12-01)